크리에이티브 메디컬 테크놀로지 홀딩스(CELZ)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.89 (+1.65%), 시가총액 $0.01B, 52주 최저~최고 $1.78 ~ $5.59.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pa
크리에이티브 메디컬 테크놀로지 홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
크리에이티브 메디컬 테크놀로지 홀딩스의 현재 주가는 $0.89 (+1.65%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
크리에이티브 메디컬 테크놀로지 홀딩스의 시가총액은 약 $0.01B입니다.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and or